Finally, in a mouse model of MAS, a significant upregulation of the IFNγ pathway and an increased expression of the IFNγ-inducible chemokines CXCL9 and CXCL10 have been observed in the liver, spleen, and plasma. This evidence concerns the gene CXCL9 and macrophage activation syndrome.